Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paras Kumar Mishra

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Cardiovascular Medicine|April 8, 2024
Editorial: Nucleic acid-based therapies for cardiovascular diseasesFabio Martelli, Paras Kumar Mishra, Andrea Caporali
Frontiers in Cell and Developmental Biology|July 21, 2022
Editorial: Autophagy-Mediated Cell Survival and Death in Disease Progression and TreatmentYongqiang Chen, Yongchao Zhao, Paras Kumar Mishra
Cell Biochemistry and Biophysics|April 28, 2010
MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNAParas Kumar Mishra, Naira Metreveli, Suresh C Tyagi
Stem Cell Reviews and Reports|November 4, 2016
Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell TherapyPriyanka Prathipati, Shyam Sundar Nandi, Paras Kumar Mishra
Cell Biochemistry and Biophysics|June 26, 2013
Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita heartsVishalakshi Chavali, Suresh C Tyagi, Paras Kumar Mishra
Biochimica Et Biophysica Acta|September 24, 2013
Cardiac matrix: a clue for future therapyParas Kumar Mishra, Srikanth Givvimani, Vishalakshi Chavali, et al.
Journal of Cellular and Molecular Medicine|March 27, 2009
MicroRNAs as a therapeutic target for cardiovascular diseasesParas Kumar Mishra, Neetu Tyagi, Munish Kumar, et al.
Biochemical and Biophysical Research Communications|September 15, 2010
Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathyParas Kumar Mishra, Srikanth Givvimani, Naira Metreveli, et al.
Canadian Journal of Physiology and Pharmacology|March 8, 2012
Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrixParas Kumar Mishra, Vishalakshi Chavali, Naira Metreveli, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2014
Generating double knockout mice to model genetic intervention for diabetic cardiomyopathy in humansVishalakshi Chavali, Shyam Sundar Nandi, Shree Ram Singh, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Cardiovascular Medicine|April 8, 2024
Editorial: Nucleic acid-based therapies for cardiovascular diseasesFabio Martelli, Paras Kumar Mishra, Andrea Caporali
Frontiers in Cell and Developmental Biology|July 21, 2022
Editorial: Autophagy-Mediated Cell Survival and Death in Disease Progression and TreatmentYongqiang Chen, Yongchao Zhao, Paras Kumar Mishra
Cell Biochemistry and Biophysics|April 28, 2010
MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNAParas Kumar Mishra, Naira Metreveli, Suresh C Tyagi
Stem Cell Reviews and Reports|November 4, 2016
Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell TherapyPriyanka Prathipati, Shyam Sundar Nandi, Paras Kumar Mishra
Cell Biochemistry and Biophysics|June 26, 2013
Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita heartsVishalakshi Chavali, Suresh C Tyagi, Paras Kumar Mishra
Biochimica Et Biophysica Acta|September 24, 2013
Cardiac matrix: a clue for future therapyParas Kumar Mishra, Srikanth Givvimani, Vishalakshi Chavali, et al.
Journal of Cellular and Molecular Medicine|March 27, 2009
MicroRNAs as a therapeutic target for cardiovascular diseasesParas Kumar Mishra, Neetu Tyagi, Munish Kumar, et al.
Biochemical and Biophysical Research Communications|September 15, 2010
Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathyParas Kumar Mishra, Srikanth Givvimani, Naira Metreveli, et al.
Canadian Journal of Physiology and Pharmacology|March 8, 2012
Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrixParas Kumar Mishra, Vishalakshi Chavali, Naira Metreveli, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2014
Generating double knockout mice to model genetic intervention for diabetic cardiomyopathy in humansVishalakshi Chavali, Shyam Sundar Nandi, Shree Ram Singh, et al.
Pageof 3